Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
The present invention relates to compounds of formula (I): wherein R 1 is C 1-6 alkylamino, C 1-6 alkoxy, or C 3-7 cycloalkyloxy; m is an integer having a value of 3 to 6; n is an integer having a value of 0 to 4; and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.
1. A method for treating asthma, said method comprising administering to a human subject in need thereof a compound of formula (I):
wherein;
R 1 is (1S)-1-methylbutyloxy;
m is an integer having a value of 4 to 6;
n is an integer having a value of 2 to 4;
or a salt thereof.
2. The method of claim 1 , wherein the compound or a salt thereof selected from the list consisting of:
6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[4-(1-piperidinyl)butyl]-7,9-dihydro-8H-purin-8-one;
6-amino-9-[4-(hexahydro-1H-azepin-1-yl)butyl]-2-{[(1S)-1-methylbutyl]oxy}-7,9-dihydro-8H-purin-8-one, and;
6-amino-9-[5-(hexahydro-1H-azepin-1-yl)pentyl]-2-{[(1S)-1-methylbutyl]oxy}-7,9-dihydro-8H-purin-8-one;
and salts thereof.
3. The method of claim 1 wherein said salt is a pharmaceutically acceptable salt.
4. The method of claim 1 wherein said compound is a free base.